JMP Securities analyst Joe Goodwin downgrades Duck Creek Technologies (NASDAQ:DCT) from Market Outperform to Market Perform.
Pfizer Touts Positive Data From Global Maternal Immunization Trial For Its Bivalent RSV Vaccine Candidate
Pfizer Inc (NYSE:PFE) announced topline data from the Phase 3 MATISSE trial investigating its bivalent RSV prefusion vaccine candidate administered to…